185 related articles for article (PubMed ID: 36184821)
1. Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta-analysis.
Kharel S; Ojha R; Khanal S
Brain Behav; 2022 Nov; 12(11):e2779. PubMed ID: 36184821
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
3. Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study.
Zhu H; Deng X; Feng L; Lian Y; Han X; Guo Z; Gou Y; Du Y; Xie L; Yao D; Liu Y; Wu Q; Lan S; Liu K; Zhan P; Wang X; Dang J; Hou Y; Chen K; Zhu Y; Shi Y; Yu Y; Xiao B; Zhu S; Meng H
CNS Neurosci Ther; 2022 Jul; 28(7):1072-1080. PubMed ID: 35429132
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.
Liu Y; Wang Y; Li X; Wu X
Front Pediatr; 2024; 12():1336744. PubMed ID: 38711491
[TBL] [Abstract][Full Text] [Related]
6. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes.
Suo GH; Zheng YQ; Wu YJ; Tang JH
Acta Neurol Belg; 2021 Oct; 121(5):1265-1273. PubMed ID: 33590471
[TBL] [Abstract][Full Text] [Related]
7. Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
Kim JH; Lee SK; Loesch C; Namgoong K; Lee HW; Hong SB;
Epilepsia; 2017 Apr; 58(4):e70-e74. PubMed ID: 28395124
[TBL] [Abstract][Full Text] [Related]
8. The effects of oxcarbazepine, levetiracetam, and lamotrigine on semen quality, sexual function, and sex hormones in male adults with epilepsy.
Wu D; Chen L; Ji F; Si Y; Sun H
Epilepsia; 2018 Jul; 59(7):1344-1350. PubMed ID: 29889310
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide add-on therapy for focal epilepsy.
Babar RK; Bresnahan R; Gillespie CS; Michael BD
Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study.
Zhao B; Liao S; Zhong X; Luo Y; Hong S; Cheng M; Zhang J; Li T; Jiang L
Front Neurol; 2022; 13():909191. PubMed ID: 35720076
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M; Al-Bachari S; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine add-on for drug-resistant focal epilepsy.
Bresnahan R; Atim-Oluk M; Marson AG
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
[TBL] [Abstract][Full Text] [Related]
17. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
19. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
